1st Quarter - Report

THE DUBERSTEIN GROUP INC. for PHRMA INC.

Firm
Client
Income
$75,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug Pricing

LobbyistCovered position, as disclosed
BRIAN GRIFFIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Pay-Fors. Medicare Part D: HR 1625 (Royce) - Consolidated Appropriations Act, 2018 HR 1892 (Larson) - Bipartisan Budget Act of 2018

LobbyistCovered position, as disclosed
ANNE ELLIOTT BRADBURY —
BRIAN GRIFFIN —
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1625 (115th), H.R. 1892 (115th)

Medicare/Medicaid MMM

Medicare Part D: HR 1625 (Royce) - Consolidated Appropriations Act, 2018 HR 1892 (Larson) - Bipartisan Budget Act of 2018 Pay-fors.

LobbyistCovered position, as disclosed
ANNE ELLIOTT BRADBURY —
DANIEL P MEYER —
DAVID J SCHIAPPA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1625 (115th), H.R. 1892 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.